Elise Foucault , Valérie Macioce , Marion Soler , Yves-Marie Pers , Jean-Baptiste Bonnet , Antoine Avignon , Nicolas Chevalier , Ariane Sultan
{"title":"根据肥胖状况坚持乳腺癌和宫颈癌筛查指南:法国横断面多中心调查","authors":"Elise Foucault , Valérie Macioce , Marion Soler , Yves-Marie Pers , Jean-Baptiste Bonnet , Antoine Avignon , Nicolas Chevalier , Ariane Sultan","doi":"10.1016/j.pmedr.2026.103405","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To assess breast and cervical cancer screening rates among women according to body mass index (BMI).</div></div><div><h3>Methods</h3><div>This cross-sectional study used anonymous self-administered questionnaires given to women from three French university hospitals with normal weight (BMI 18.5–25 kg/m<sup>2</sup>), class I obesity (BMI 30–35 kg/m<sup>2</sup>), or class II obesity (BMI ≥ 35 kg/m<sup>2</sup>) in 2020–2021. Up-to-date screening was defined according to national guidelines: biennial clinical breast exams and mammograms for women aged 50–74, and triennial cervical samples for women aged 25–65, excluding those with prior cancer or related surgery. Screening rates and gynecological follow-up were compared across BMI groups.</div></div><div><h3>Results</h3><div>Among 439 women (20% class I, 22% class II obesity), 178 and 370 were eligible for breast and cervical cancer screening, respectively. Women with class I and II obesity were less likely to be up-to-date for clinical breast exams (Odds Ratio [95% confidence interval] 2.35[1.06,5.20] and 2.68[1.12,6.42], respectively), mammography (4.43[1.49,13.18] and 4.08[1.22,13.62]), and cervical samples (2.23[1.09,4.54] and 2.85[1.42,5.72]). Class II obesity was associated with more frequent follow-up by general practitioners (<em>p</em> < 0.05).</div></div><div><h3>Conclusion<strong>s</strong></h3><div>Women with obesity are less likely to receive recommended gynecological cancer screenings than normal-weight peers. These disparities call for more inclusive healthcare strategies.</div><div><strong>Trial registration</strong>: <span><span>NCT04357652</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":38066,"journal":{"name":"Preventive Medicine Reports","volume":"63 ","pages":"Article 103405"},"PeriodicalIF":2.4000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adherence to breast and cervical cancer screening guidelines according to obesity status: a French cross-sectional multicenter survey\",\"authors\":\"Elise Foucault , Valérie Macioce , Marion Soler , Yves-Marie Pers , Jean-Baptiste Bonnet , Antoine Avignon , Nicolas Chevalier , Ariane Sultan\",\"doi\":\"10.1016/j.pmedr.2026.103405\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>To assess breast and cervical cancer screening rates among women according to body mass index (BMI).</div></div><div><h3>Methods</h3><div>This cross-sectional study used anonymous self-administered questionnaires given to women from three French university hospitals with normal weight (BMI 18.5–25 kg/m<sup>2</sup>), class I obesity (BMI 30–35 kg/m<sup>2</sup>), or class II obesity (BMI ≥ 35 kg/m<sup>2</sup>) in 2020–2021. Up-to-date screening was defined according to national guidelines: biennial clinical breast exams and mammograms for women aged 50–74, and triennial cervical samples for women aged 25–65, excluding those with prior cancer or related surgery. Screening rates and gynecological follow-up were compared across BMI groups.</div></div><div><h3>Results</h3><div>Among 439 women (20% class I, 22% class II obesity), 178 and 370 were eligible for breast and cervical cancer screening, respectively. Women with class I and II obesity were less likely to be up-to-date for clinical breast exams (Odds Ratio [95% confidence interval] 2.35[1.06,5.20] and 2.68[1.12,6.42], respectively), mammography (4.43[1.49,13.18] and 4.08[1.22,13.62]), and cervical samples (2.23[1.09,4.54] and 2.85[1.42,5.72]). Class II obesity was associated with more frequent follow-up by general practitioners (<em>p</em> < 0.05).</div></div><div><h3>Conclusion<strong>s</strong></h3><div>Women with obesity are less likely to receive recommended gynecological cancer screenings than normal-weight peers. These disparities call for more inclusive healthcare strategies.</div><div><strong>Trial registration</strong>: <span><span>NCT04357652</span><svg><path></path></svg></span>.</div></div>\",\"PeriodicalId\":38066,\"journal\":{\"name\":\"Preventive Medicine Reports\",\"volume\":\"63 \",\"pages\":\"Article 103405\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2026-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Preventive Medicine Reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2211335526000331\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/2/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Preventive Medicine Reports","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211335526000331","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
Adherence to breast and cervical cancer screening guidelines according to obesity status: a French cross-sectional multicenter survey
Objective
To assess breast and cervical cancer screening rates among women according to body mass index (BMI).
Methods
This cross-sectional study used anonymous self-administered questionnaires given to women from three French university hospitals with normal weight (BMI 18.5–25 kg/m2), class I obesity (BMI 30–35 kg/m2), or class II obesity (BMI ≥ 35 kg/m2) in 2020–2021. Up-to-date screening was defined according to national guidelines: biennial clinical breast exams and mammograms for women aged 50–74, and triennial cervical samples for women aged 25–65, excluding those with prior cancer or related surgery. Screening rates and gynecological follow-up were compared across BMI groups.
Results
Among 439 women (20% class I, 22% class II obesity), 178 and 370 were eligible for breast and cervical cancer screening, respectively. Women with class I and II obesity were less likely to be up-to-date for clinical breast exams (Odds Ratio [95% confidence interval] 2.35[1.06,5.20] and 2.68[1.12,6.42], respectively), mammography (4.43[1.49,13.18] and 4.08[1.22,13.62]), and cervical samples (2.23[1.09,4.54] and 2.85[1.42,5.72]). Class II obesity was associated with more frequent follow-up by general practitioners (p < 0.05).
Conclusions
Women with obesity are less likely to receive recommended gynecological cancer screenings than normal-weight peers. These disparities call for more inclusive healthcare strategies.